FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Evan Hersh

Research Profile

Disorders

Physiology

Chemicals & Drugs

Anatomy

Lymphocytes

Procedures

Co-author Network

Publications

TOP 3
Joanne M Jeter; Lee D Cranmer; Evan M Hersh
Ipilimumab pharmacotherapy in patients with metastatic melanoma.
Evan M Hersh; Steven J O'Day; John Powderly; Khuda D Khan; Anna C Pavlick; Lee D Cranmer; Wolfram E Samlowski; Geoffrey M Nichol; Michael J Yellin; Jeffrey S Weber
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
Stacy Moulder; Navneet Dhillon; Chaan Ng; David Hong; Jennifer Wheler; Aung Naing; Susan Tse; Amy La Paglia; Robert Dorr; Evan M Hersh; Michelle Boytim; Razelle Kurzrock
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Evan Hersh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Joanne M Jeter; Lee D Cranmer; Evan M Hersh
Ipilimumab pharmacotherapy in patients with metastatic melanoma.
Clinical Medicine Insights. Oncology 2012;6():275-86.
2011: Evan M Hersh; Steven J O'Day; John Powderly; Khuda D Khan; Anna C Pavlick; Lee D Cranmer; Wolfram E Samlowski; Geoffrey M Nichol; Michael J Yellin; Jeffrey S Weber
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
Investigational new drugs 2011;29(3):489-98.
2010: Stacy Moulder; Navneet Dhillon; Chaan Ng; David Hong; Jennifer Wheler; Aung Naing; Susan Tse; Amy La Paglia; Robert Dorr; Evan M Hersh; Michelle Boytim; Razelle Kurzrock
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer.
Investigational new drugs 2010;28(5):634-40.
2010: Jeffrey S Weber; Wolfram E Samlowski; Rene Gonzalez; Antoni Ribas; Joe Stephenson; Steven O'Day; Takami Sato; Robert Dorr; Kathryn Grenier; Evan M Hersh
A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma.
Cancer 2010;116(15):3683-91.
2010: Steven J Cohen; Mark M Zalupski; Manuel R Modiano; Paul Conkling; Yehuda Z Patt; Peg Davis; Robert T Dorr; Michelle L Boytim; Evan M Hersh
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
Cancer chemotherapy and pharmacology 2010;66(2):287-94.
2010: Kazuo Koyanagi; Steven J O'Day; Peter D Boasberg; Michael B Atkins; He-Jing Wang; Rene Gonzalez; Karl Lewis; John A Thompson; Clay M Anderson; Jose Lutzky; Thomas T Amatruda; Evan M Hersh; Jon Richards; Jeffrey S Weber; Dave S B Hoon
Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(8):2402-8.
2010: Antoni Ribas; Luis H Camacho; Sun Min Lee; Evan M Hersh; Charles K Brown; Jon M Richards; Maria Jovie Rodriguez; Victor G Prieto; John A Glaspy; Denise K Oseguera; Jackie Hernandez; Arturo Villanueva; Bartosz Chmielowski; Peggie Mitsky; Nadège Bercovici; Ernesto Wasserman; Didier Landais; Merrick I Ross
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma.
Journal of translational medicine 2010;8():89.
2010: Lee D Cranmer; Joanne M Jeter; Sherif S Morgan; Evan M Hersh; Baldassarre Stea
Whole-brain radiation therapy in melanoma: an open question.
The lancet oncology 2010;11(1):13; author reply 13-4.
2010: Evan M Hersh; Steven J O'Day; Antoni Ribas; Wolfram E Samlowski; Michael S Gordon; Deganit E Shechter; Alicia A Clawson; Rene Gonzalez
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma.
Cancer 2010;116(1):155-63.
2009: Steven J O'Day; Michael B Atkins; Peter Boasberg; He-Jing Wang; John A Thompson; Clay M Anderson; Rene Gonzalez; Jose Lutzky; Thomas Amatruda; Evan M Hersh; Jeffrey S Weber
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6207-12.
2008: Jeffrey S Weber; Steven O'Day; Walter Urba; John Powderly; Geoff Nichol; Michael Yellin; Jolie Snively; Evan M Hersh
Phase I/II study of ipilimumab for patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(36):5950-6.
2008: David F McDermott; Jeffrey A Sosman; Rene Gonzalez; F Stephen Hodi; Gerald P Linette; Jon Richards; James Jakub; Muralidhar Beeram; Stefano Tarantolo; Sanjiv Agarwala; Gary Frenette; Igor Puzanov; Lee Cranmer; Karl Lewis; John Kirkwood; J Michael White; Chenghua Xia; Kiran Patel; Evan M Hersh
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(13):2178-85.
2008: Jeffrey Weber; William Boswell; John Smith; Evan M Hersh; Jolie Snively; Mella Diaz; Sabrina Miles; Xiding Liu; Mihail Obrocea; Zhiyong Qiu; Adrian Bot
Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(2):215-23.
2007: Lee D Cranmer; Evan M Hersh
The role of the CTLA4 blockade in the treatment of malignant melanoma.
Cancer investigation 2007;25(7):613-31.
2007: Tomislav Dragovich; Michael S Gordon; David S Mendelson; Lucas Wong; Manuel Modiano; H-H Sherry Chow; Betty K Samulitis; Steven J O'Day; Kathryn Grenier; Evan M Hersh; Robert T Dorr
Phase I trial of imexon in patients with advanced malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1779-84.
2006: Alan Pourpak; Ross O Meyers; Betty K Samulitis; H-H Sherry Chow; Carole Y Kepler; Mary Ann Raymond; Evan M Hersh; Robert T Dorr
Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice.
Anti-cancer drugs 2006;17(10):1179-84.
2006: Agop Bedikian; Michael Millward; Hubert Pehamberger; Robert Conry; Martin Gore; Uwe Trefzer; Anna C Pavlick; Ronald C DeConti; Evan M Hersh; Peter Hersey; John M Kirkwood; Frank G Haluska
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4738-45.
2005: Scot W Ebbinghaus; Eric Rubin; Evan M Hersh; Lee D Cranmer; Peter L Bonate; Robert J Fram; Antti Jekunen; Steven D Weitman; Lisa A Hammond
A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7807-16.
2005: David W Nyman; Kimberley J Campbell; Evan M Hersh; Kristen Long; Kelly Richardson; Vuong Trieu; Neil Desai; Michael J Hawkins; Daniel Von Hoff
Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7785-93.
2005: Lee D Cranmer; Katrina T Trevor; Surekha Bandlamuri; Evan M Hersh
Rodent models of brain metastasis in melanoma.
Melanoma research 2005;15(5):325-56.
2004: Katrina T Trevor; Cathleen Cover; Yvette W Ruiz; Emmanuel T Akporiaye; Evan M Hersh; Didier Landais; Rachel R Taylor; Alan D King; Richard E Walters
Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application.
Cancer immunology, immunotherapy : CII 2004;53(8):705-14.
2004: Robert P Whitehead; James Moon; S Spence McCachren; Evan M Hersh; Wolfram E Samlowski; J Thaddeus Beck; Nerses S Tchekmedyian; vernon sondak
A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Cancer 2004;100(8):1699-704.
2004: Lee D Cranmer; Katrina T Trevor; Evan M Hersh
Clinical applications of dendritic cell vaccination in the treatment of cancer.
Cancer immunology, immunotherapy : CII 2004;53(4):275-306.
2003: Julia A Coronella-Wood; Evan M Hersh
Naturally occurring B-cell responses to breast cancer.
Cancer immunology, immunotherapy : CII 2003;52(12):715-38.
2003: Young T Kim; Evan M Hersh; Katrina T Trevor
Feasibility to generate monocyte-derived dendritic cell from coculture with melanoma tumor cells in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-4.
American journal of reproductive immunology (New York, N.Y. : 1989) 2003;49(4):230-8.
2002: Julia A Coronella; Catherine Spier; Matthew Welch; Katrina T Trevor; Alison T Stopeck; Hugo V Villar; Evan M Hersh
Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(4):1829-36.
2002: Sanjiv S Agarwala; John Glaspy; Steven J O'Day; Malcolm Mitchell; John C Gutheil; Eric Whitman; Rene Gonzalez; Evan M Hersh; Lynn Feun; Robert Belt; Frank Meyskens; Kristoffer Hellstrand; Diana Wood; John M Kirkwood; Kurt Gehlsen; Peter Naredi
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):125-33.
2001: Katrina T Trevor; Evan M Hersh; Jacqueline L Brailey; Jean-Marc Balloul; Bruce Acres
Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2.
Cancer immunology, immunotherapy : CII 2001;50(8):397-407.
2001: Alison T Stopeck; A Jones; Evan M Hersh; J A Thompson; D M Finucane; J C Gutheil; R Gonzalez
Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2285-91.
2001: evan unger; Evan M Hersh; Mani A Vannan; T O Matsunaga; Thomas P McCreery
Local drug and gene delivery through microbubbles.
Progress in cardiovascular diseases 2001;44(1):45-54.
2001: evan unger; Evan M Hersh; Mani A Vannan; Thomas P McCreery
Gene delivery using ultrasound contrast agents.
Echocardiography (Mount Kisco, N.Y.) 2001;18(4):355-61.
2001: Robert T Dorr; JD Liddil; SM Sami; William A Remers; Evan M Hersh; David S Alberts
Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators.
Anti-cancer drugs 2001;12(3):213-20.
2001: Charles W Taylor; Robert T Dorr; PT Fanta; Evan M Hersh; Sydney E Salmon
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2001;47(1):83-8.
2000: Alison T Stopeck; A Gessner; Thomas P Miller; Evan M Hersh; C S Johnson; Haiyan Cui; Yvette M Frutiger; Thomas M Grogan
Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):3904-9.
2000: PR Clark; Alison T Stopeck; SE Parker; Evan M Hersh
Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft.
Cellular immunology 2000;204(2):96-104.
2000: PR Clark; Alison T Stopeck; M Ferrari; SE Parker; Evan M Hersh
Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.
Cancer gene therapy 2000;7(6):853-60.
2000: Eugene W Gerner; Evan M Hersh; Michael E Pennington; Tom C Tsang; D Harris; Farha H Vasanwala; Jacqueline L Brailey
Heat-inducible vectors for use in gene therapy.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2000;16(2):171-81.
2000: Douglas F. Lake; W C Huynh; Evan M Hersh
Natural and induced human antibody response to cancer.
Cancer investigation 2000;18(5):480-9.
1999: Evanthia C Galanis; Evan M Hersh; Alison T Stopeck; R Gonzalez; Patrick A Burch; Catherine Spier; Emmanuel T Akporiaye; J J Rinehart; John H Edmonson; R E Sobol; C Forscher; vernon sondak; Bradley D Lewis; E C Unger; M O'Driscoll; L Selk; Joseph Rubin
Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3313-23.
1999: PR Clark; Alison T Stopeck; Jacqueline L Brailey; Q Wang; J McArthur; MH Finer; Evan M Hersh
Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells.
Cancer gene therapy 1999;6(5):437-46.
1999: Emmanuel T Akporiaye; Evan M Hersh
Clinical aspects of intratumoral gene therapy.
Current opinion in molecular therapeutics 1999;1(4):443-53.
1999: PR Clark; Evan M Hersh
Cationic lipid-mediated gene transfer: current concepts.
Current opinion in molecular therapeutics 1999;1(2):158-76.
1999: Bhashyam S Iyengar; Robert T Dorr; David S Alberts; Evan M Hersh; Sydney E Salmon; William A Remers
Novel antitumor 2-cyanoaziridine-1-carboxamides.
Journal of medicinal chemistry 1999;42(3):510-4.
1999: Ana Maria Lopez; L Wallace; Robert T Dorr; M Koff; Evan M Hersh; David S Alberts
Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia.
Cancer chemotherapy and pharmacology 1999;44(4):303-6.
1999: Kim Margolin; PY Liu; Joseph M Unger; WS Fletcher; Lawrence E Flaherty; W J Urba; Evan M Hersh; L E Hutchins; Jeffrey A Sosman; John W Smith; Geoffrey R Weiss; vernon sondak
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.
Journal of cancer research and clinical oncology 1999;125(5):292-6.
1998: Alison T Stopeck; Evan M Hersh; Jacqueline L Brailey; PR Clark; J Norman; SE Parker
Transfection of primary tumor cells and tumor cell lines with plasmid DNA/lipid complexes.
Cancer gene therapy 1998;5(2):119-26.
1997: Evan M Hersh; Alison T Stopeck
Advances in the biological therapy and gene therapy of malignant disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2623-9.
1997: Evan M Hersh
Foundations of clinical cancer research: perspective for the 21st century.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2551-3.
1997: Evan M Hersh; Alison T Stopeck
Recent advances in the treatment of malignant melanoma with gene therapy.
Molecular medicine (Cambridge, Mass.) 1997;3(10):636-51.
1997: Laura K Shawver; D P Schwartz; E Mann; Hui Chen; J Tsai; L Chu; L Taylorson; M Longhi; S Meredith; L Germain; J S Jacobs; Cho Tang; Axel Ullrich; Michael Berens; Evan M Hersh; Gerald McMahon; KP Hirth; T J Powell
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(7):1167-77.
1997: W Waddill; W Wright; E Unger; Alison T Stopeck; Emmanuel T Akporiaye; D Harris; Thomas M Grogan; Samuel F Schluter; Evan M Hersh; S Stahl
Human gene therapy for melanoma: CT-guided interstitial injection.
AJR. American journal of roentgenology 1997;169(1):63-7.
1997: J Rinehart; Evan M Hersh; B Issell; Pierre L Triozzi; W Buhles; J Neidhart
Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940.
Cancer investigation 1997;15(5):403-10.
1997: Gillian Paine-Murrieta; Charles W Taylor; R A Curtis; M H Lopez; Robert T Dorr; C S Johnson; C Y Funk; F Thompson; Evan M Hersh
Human tumor models in the severe combined immune deficient (scid) mouse.
Cancer chemotherapy and pharmacology 1997;40(3):209-14.
1997: J A Park; E Wang; Robert A Kurt; Samuel F Schluter; Evan M Hersh; Emmanuel T Akporiaye
Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.
Cancer gene therapy 1997;4(1):42-50.
1997: Alison T Stopeck; Evan M Hersh; Emmanuel T Akporiaye; David T Harris; Thomas M Grogan; E Unger; James Warneke; Samuel F Schluter; S Stahl
Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):341-9.
1997: Tom C Tsang; David T Harris; Emmanuel T Akporiaye; R S Chu; Jacqueline L Brailey; F Liu; Farha H Vasanwala; Samuel F Schluter; Evan M Hersh
Mammalian expression vector with two multiple cloning sites for expression of two foreign genes.
BioTechniques 1997;22(1):68.
1996: E A Petersen; J B Grayson; Evan M Hersh; R T Dorr; S M Chiang; M Oka; R T Proffitt
Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model.
The Journal of antimicrobial chemotherapy 1996;38(5):819-28.
1996: Mark R Wallace; Ronald B Moss; H J Beecham; C J Grace; Evan M Hersh; E Peterson; R Murphy; D H Shepp; F P Siegal; JL Turner; S Safrin; Dennis J Carlo; Alexandra M Levine
Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(4):358-62.
1996: SE Parker; S Khatibi; Michal Margalith; D Anderson; M Yankauckas; S H Gromkowski; T Latimer; D Lew; M Marquet; Marston Manthorpe; Peter Hobart; Evan M Hersh; Alison T Stopeck; Jon Norman
Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Cancer gene therapy 1996;3(3):175-85.
1996: M C Panelli; E Wang; S Shen; Samuel F Schluter; R M Bernstein; Evan M Hersh; Alison T Stopeck; R Gangavalli; J Barber; D Jolly; Emmanuel T Akporiaye
Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.
Cancer immunology, immunotherapy : CII 1996;42(2):99-107.
1996: T C Tsang; David T Harris; Emmanuel T Akporiaye; Samuel F Schluter; George Bowden; Evan M Hersh
Simple method for adapting DNA fragments and PCR products to all of the commonly used restriction sites.
BioTechniques 1996;20(1):51-2.
1995: Frank L Meyskens; K J Kopecky; C W Taylor; R D Noyes; R J Tuthill; Evan M Hersh; Lynn Feun; James Doroshow; Lawrence E Flaherty; vernon sondak
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study.
Journal of the National Cancer Institute 1995;87(22):1710-3.
1995: J Rinehart; Kim Margolin; Pierre L Triozzi; Evan M Hersh; M Campion; D Resta; D Levitt
Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(10):1139-44.
1995: H Zhang; Douglas F. Lake; Jose Alexandre M Barbuto; Ralph M Bernstein; W J Grimes; Evan M Hersh
A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytes.
Cancer research 1995;55(16):3584-91.
1995: L Wong; C W Taylor; E Radwanski; Evan M Hersh; S E Salmon
Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factor.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18(1):57-65.
1995: R T Dorr; J D Liddil; M K Klein; Evan M Hersh
Preclinical pharmacokinetics and antitumor activity of imexon.
Investigational new drugs 1995;13(2):113-6.
1995: Jose Alexandre M Barbuto; W J Grimes; Evan M Hersh
Antibodies to tumor necrosis factor: a component of B cell immune responses with a role in tumor/host interaction.
Cancer immunology, immunotherapy : CII 1995;40(1):31-6.
1994: M H Smith; Kit S Lam; Evan M Hersh; Michal Lebl; W J Grimes
Peptide sequences binding to MHC class I proteins.
Molecular immunology 1994;31(18):1431-7.
1994: Evan M Hersh; Emmanuel T Akporiaye; D Harris; Alison T Stopeck; E C Unger; James Warneke; S A Kradjian
Phase I study of immunotherapy of malignant melanoma by direct gene transfer.
Human gene therapy 1994;5(11):1371-84.
1994: Douglas F. Lake; Kit S Lam; L Peng; Evan M Hersh
Molecular cloning, expression and mutagenesis of an anti-insulin single chain Fv (scFv).
Molecular immunology 1994;31(11):845-56.
1994: Douglas F. Lake; Ralph M Bernstein; Evan M Hersh; H Kaymaz; Samuel F Schluter; John J Marchalonis
Construction and serological characterization of a recombinant human single chain T cell receptor.
Biochemical and biophysical research communications 1994;201(3):1502-9.
1994: C J Punt; Jose Alexandre M Barbuto; H Zhang; W J Grimes; K D Hatch; Evan M Hersh
Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes.
Cancer immunology, immunotherapy : CII 1994;38(4):225-32.
1994: Sydney E Salmon; Evan M Hersh
Sensitivity of multiple myeloma to imexon in the human tumor cloning assay.
Journal of the National Cancer Institute 1994;86(3):228-30.
1994: E A Poplin; D S Alberts; J J Rinehart; Harriet O Smith; J A Neidhart; Evan M Hersh
GM-CSF, carboplatin, doxorubicin: a phase I study.
Cancer chemotherapy and pharmacology 1994;33(4):340-6.
1993: M J Moran; J S Andris; Y Matsumato; J D Capra; Evan M Hersh
Variable region genes of anti-HIV human monoclonal antibodies: non-restricted use of the V gene repertoire and extensive somatic mutation.
Molecular immunology 1993;30(16):1543-51.
1993: William T Bellamy; A Odeleye; P Finley; B Huizenga; William S Dalton; R S Weinstein; Evan M Hersh; Thomas M Grogan
An in vivo model of human multidrug-resistant multiple myeloma in SCID mice.
The American journal of pathology 1993;142(3):691-7.
1993: Jose Alexandre M Barbuto; E L Verastegui; Evan M Hersh
The use of transformed T cell lines for clonal expansion of human B cells from peripheral blood, spleen, and tumor-infiltrating lymphocytes.
Hybridoma 1993;12(1):115-25.
1993: Evan M Hersh; T M Grogan; C Y Funk; C W Taylor
Suppression of human lymphoma development in the severe combined immune-deficient mouse by imexon therapy.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;13(2):77-83.
1993: Evan M Hersh; C Y Funk; E A Petersen; K L Ryschon; D E Mosier
Dose response and timing effects in the therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate.
International journal of immunopharmacology 1993;15(2):137-43.
1993: C F Verschraegen; Sewa S Legha; Evan M Hersh; Carl Plager; Nicholas Papadopoulos; M A Burgess
Phase II study of vindesine and dacarbazine with or without non-specific stimulation of the immune system in patients with metastatic melanoma.
European journal of cancer (Oxford, England : 1990) 1993;29A(5):708-11.
1993: Victor J Hruby; Kit S Lam; Michal Lebl; W Kazmierski; Evan M Hersh; S E Salmon
Preparation of large peptide libraries with one peptide per bead and their use for the discovery of peptides that bind to acceptors.
NIDA research monograph 1993;134():75-83.
1992: F J Feo-Zuppardi; Charles W Taylor; K Iwato; M H Lopez; Thomas M Grogan; A Odeleye; Evan M Hersh; Sydney E Salmon
Long-term engraftment of fresh human myeloma cells in SCID mice.
Blood 1992;80(11):2843-50.
1992: Evan M Hersh; C R Gschwind; C W Taylor; R T Dorr; R Taetle; S E Salmon
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro.
Journal of the National Cancer Institute 1992;84(16):1238-44.
1992: M W Konrad; S K DeWitt; E C Bradley; G Goodman; E C Groves; Evan M Hersh; R L Krigel; A Rudolph
Interferon-gamma induced by administration of recombinant interleukin-2 to patients with cancer: kinetics, dose dependence, and correlation with physiological and therapeutic response.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;12(1):55-63.
1992: Charles W Taylor; Thomas M Grogan; M H Lopez; S P Leong; A Odeleye; F J Feo-Zuppardi; Evan M Hersh
Growth and dissemination of human malignant melanoma cells in mice with severe combined immune deficiency.
Laboratory investigation; a journal of technical methods and pathology 1992;67(1):130-7.
1992: F M Muggia; T D Brown; P J Goodman; J S Macdonald; Evan M Hersh; T R Fleming; L Leichman
High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers.
Anti-cancer drugs 1992;3(3):211-7.
1992: C J Verdi; C W Taylor; M K Croghan; P Dalke; Frank L Meyskens; Evan M Hersh
Phase I study of low-dose cyclophosphamide and recombinant interleukin-2 for the treatment of advanced cancer.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;11(4):286-91.
1992: C Y Funk; J Eisman; Evan M Hersh
Treatment of the murine, retrovirus-induced lymphoproliferative immunodeficiency disease (LP-BM5) in C57BL/10 mice with the immunomodulator Imexon.
AIDS research and human retroviruses 1992;8(5):633-8.
1992: Charles W Taylor; M R Modiano; M E Woodson; S G Marcus; D S Alberts; Evan M Hersh
A phase I trial of fluorouracil, leucovorin, and recombinant interferon alpha-2b in patients with advanced malignancy.
Seminars in oncology 1992;19(2 Suppl 3):185-90.
1992: C W Taylor; E M Chase; Robert P Whitehead; J J Rinehart; J A Neidhart; R Gonzalez; P A Bunn; Evan M Hersh
A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;11(3):176-83.
1992: Mary J C Hendrix; Elisabeth A Seftor; Thomas M Grogan; Richard E B Seftor; Evan M Hersh; E A Boyse; L A Liotta; W Stetler-Stevenson; C G Ray
Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice.
Molecular and cellular probes 1992;6(1):59-65.
1992: Douglas F. Lake; T Kawamura; T Tomiyama; W E Robinson; Y Matsumoto; Y Masuho; Evan M Hersh
Generation and characterization of a human monoclonal antibody that neutralizes diverse HIV-1 isolates in vitro.
AIDS (London, England) 1992;6(1):17-24.
1992: Evan M Hersh
Immunomodulatory drugs of relevance to the management of microbial infections.
Advances in experimental medicine and biology 1992;319():1-11.
1991: Evan M Hersh; B S Metch; F M Muggia; T D Brown; Robert P Whitehead; G Thomas Budd; J J Rinehart; E D Crawford; J D Bonnet; B C Behrens
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(6):426-31.
1991: Kit S Lam; S E Salmon; Evan M Hersh; V J Hruby; W M Kazmierski; Richard J Knapp
A new type of synthetic peptide library for identifying ligand-binding activity.
Nature 1991;354(6348):82-4.
1991: T D Brown; P Goodman; T Fleming; J S Macdonald; Evan M Hersh; T J Braun
A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: a Southwest Oncology Group study.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(5):376-8.
1991: Robert P Whitehead; K J Kopecky; M K Samson; J J Costanzi; R B Natale; Lynn Feun; Evan M Hersh; J J Rinehart
Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group study.
Journal of the National Cancer Institute 1991;83(17):1250-2.
1991: S H Pincus; Robert L Cole; Evan M Hersh; Douglas F. Lake; Y Masuho; PAUL DURDA; J McClure
In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(12):4315-24.
1991: D C Montefiori; I Y Zhou; B Barnes; Douglas F. Lake; Evan M Hersh; Y Masuho; L B Lefkowitz
Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus.
Virology 1991;182(2):635-43.
1991: Evan M Hersh; C Y Funk; K L Ryschon; E A Petersen; D E Mosier
Effective therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate.
AIDS research and human retroviruses 1991;7(6):553-61.
1991: T Tomiyama; Douglas F. Lake; Y Masuho; Evan M Hersh
Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum.
Biochemical and biophysical research communications 1991;177(1):279-85.
1991: Evan M Hersh; G Brewton; D Abrams
Ditiocarb useful in HIV therapy.
Nursing times 1991;87(21):10.
1991: Anita S Chong; J K Pinkard; Kit S Lam; P Scuderi; Evan M Hersh; W J Grimes
Ability of cell-sized beads bearing tumor cell membrane proteins to stimulate LAK cells to secrete interferon-gamma and tumor necrosis factor-alpha.
Cellular immunology 1991;134(1):96-110.
1991: Evan M Hersh; G Brewton; D Abrams; J Bartlett; J Galpin; P Gill; R Gorter; M Gottlieb; J J Jonikas; S Landesman
Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study.
JAMA : the journal of the American Medical Association 1991;265(12):1538-44.
1991: Anita S Chong; D E Bier; W J Grimes; Evan M Hersh
Gamma-irradiated peripheral blood mononuclear cells can express LAK activity.
International journal of cell cloning 1991;9(1):65-77.
1991: Evan M Hersh
Current status of immunotherapy of patients with HIV-infection.
International journal of immunopharmacology 1991;13 Suppl 1():9-18.
1990: Robert P Whitehead; T Fleming; J S Macdonald; P J Goodman; J Neefe; T J Braun; L J Swinnen; Evan M Hersh
A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.
Journal of biological response modifiers 1990;9(6):588-91.
1990: N I Goldstein; R Nagle; H Villar; Evan M Hersh; P B Fisher
Isolation and characterization of a human monoclonal antibody which reacts with breast and colorectal carcinoma.
Anticancer research 1990;10(6):1491-500.
1990: W Edward Robinson; T Kawamura; Douglas F. Lake; Y Masuho; W M Mitchell; Evan M Hersh
Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro.
Journal of virology 1990;64(11):5301-5.
1990: F L Meyskens; K Kopecky; M Samson; Evan M Hersh; J Macdonald; H Jaffe; J Crowley; C Coltman
Recombinant human interferon gamma: adverse effects in high-risk stage I and II cutaneous malignant melanoma.
Journal of the National Cancer Institute 1990;82(12):1071.
1990: M D Halpern; Evan M Hersh; D E Yocum
Diethyldithiocarbamate, a novel immunomodulator, prolongs survival in autoimmune MRL-lpr/lpr mice.
Clinical immunology and immunopathology 1990;55(2):242-54.
1990: W Edward Robinson; T Kawamura; Miroslaw K Gorny; Douglas F. Lake; J Y Xu; Y Matsumoto; T Sugano; Y Masuho; W M Mitchell; Evan M Hersh
Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(8):3185-9.
1990: M W Konrad; George P Hemstreet; Evan M Hersh; P W Mansell; R Mertelsmann; Jonathan E Kolitz; E C Bradley
Pharmacokinetics of recombinant interleukin 2 in humans.
Cancer research 1990;50(7):2009-17.
1990: Evan M Hersh; C Y Funk; E A Petersen; D E Mosier
Biological activity of diethyldithiocarbamate (Ditiocarb, Imuthiol) in an animal model of retrovirus-induced immunodeficiency disease and in clinical trials in patients with HIV infection. The Ditiocarb Study Group.
Developments in biological standardization 1990;72():355-63.
1990: Anita S Chong; B Ybarrondo; W J Grimes; Evan M Hersh; P Scuderi
Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha.
Cancer immunology, immunotherapy : CII 1990;31(4):255-9.
1989: Anita S Chong; P Scuderi; W J Grimes; Evan M Hersh
Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(6):2133-9.
1989: P S Charnetsky; R A Greisman; S E Salmon; Evan M Hersh; P Scuderi
Increased peripheral blood leukocyte cytotoxic activity in cancer patients during the continuous intravenous administration of recombinant human tumor necrosis factor.
Journal of clinical immunology 1989;9(1):34-8.
1989: Evan M Hersh; J L Murray; Waun Ki Hong; M G Rosenblum; James M Reuben; R Weilbaecher; A N Sarwal; E C Bradley; M Konrad; Frank C Arnett
Phase I study of cancer therapy with recombinant interleukin-2 administered by intravenous bolus injection.
Biotherapy (Dordrecht, Netherlands) 1989;1(3):215-26.
1989: J E Schwartz; P Scuderi; C Wiggins; A Rudolph; Evan M Hersh
A phase I trial of recombinant tumor necrosis factor (rTNF) administered by continuous intravenous infusion in patients with disseminated malignancy.
Biotherapy (Dordrecht, Netherlands) 1989;1(3):207-14.
1989: G W Brewton; Evan M Hersh; A Rios; P W Mansell; B Hollinger; James M Reuben
A pilot study of diethyldithiocarbamate in patients with acquired immune deficiency syndrome (AIDS) and the AIDS-related complex.
Life sciences 1989;45(26):2509-20.
1989: C S Kaplan; E A Petersen; D Yocum; Evan M Hersh
A randomized, controlled dose response study of intravenous sodium diethyldithiocarbamate in patients with advanced human immunodeficiency virus infection.
Life sciences 1989;45(22):iii-ix.
1989: Douglas F. Lake; T Sugano; Y Matsumoto; Y Masuho; E A Petersen; P Feorino; Evan M Hersh
A hybridoma producing human monoclonal antibody specific for glycoprotein 120 kDa of human immunodeficiency virus (HIV-1.
Life sciences 1989;45(16):iii-x.
1989: Anita S Chong; A Aleksijevic; P Scuderi; Evan M Hersh; W J Grimes
Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets.
Cancer immunology, immunotherapy : CII 1989;29(4):270-8.
1989: Evan M Hersh; P Scuderi; W J Grimes; A Chong; Jacqueline L Brailey; C R Gschwind; Sydney E Salmon
Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatants.
Cancer immunology, immunotherapy : CII 1989;30(1):65-70.
1988: Anita S Chong; Evan M Hersh; W J Grimes
Blocking of lymphokine activated killer (LAK) cell mediated cytotoxicity by cell-sized beads bearing tumor cell proteins.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(12):4418-24.
1988: T Sugano; Y Masuho; Y Matsumoto; Douglas F. Lake; C Gschwind; E A Petersen; Evan M Hersh
Human monoclonal antibody against glycoproteins of human immunodeficiency virus.
Biochemical and biophysical research communications 1988;155(3):1105-12.
1988: R M Rifkin; Evan M Hersh; Sydney E Salmon
A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
Behring Institute Mitteilungen 1988;(83):125-33.
1988: M J Keating; M Scouros; S Murphy; H Kantarjian; J Hester; K B McCredie; Evan M Hersh; Emil J Freireich
Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia.
Leukemia 1988;2(3):157-64.
1988: Evan M Hersh; E A Petersen
The AIDS epidemic: AIDS research in the life sciences.
Life sciences 1988;42(20):i-iv.
1988: Evan M Hersh; T P Miller
Malignant lymphomas in patients with human immunodeficiency virus infection.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1988;112():54-62.
1988: Evan M Hersh; E A Petersen; D E Yocum; S R Gorman; M J Darragh; C R Gschwind; G W Brewton; J A Reuben
Immunological characteristics and potential approaches to immunotherapy of HIV infection.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1988;112():17-26.
1987: J L Lepe-Zuniga; P W Mansell; Evan M Hersh
Idiopathic production of interleukin-1 in acquired immune deficiency syndrome.
Journal of clinical microbiology 1987;25(9):1695-700.
1987: R Joseph Babaian; James L Murray; L M Lamki; T P Haynie; Evan M Hersh; Michael G Rosenblum; H J Glenn; M W Unger; Dennis J Carlo; A C von Eschenbach
Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276.
The Journal of urology 1987;137(3):439-43.
1987: J L Murray; J M Reuben; T L Smith; E A Gehan; S M Koretz; Evan M Hersh
A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
Journal of biological response modifiers 1987;6(1):56-68.
1987: James L Murray; Michael G Rosenblum; L Lamki; T P Haynie; H J Glenn; Carl Plager; M W Unger; Dennis J Carlo; Evan M Hersh
Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
NCI monographs : a publication of the National Cancer Institute 1987;(3):3-9.
1987: James L Murray; Michael G Rosenblum; L Lamki; H J Glenn; Z Krizan; Evan M Hersh; Carl Plager; Richard Bartholomew; M W Unger; Dennis J Carlo
Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(1):25-33.
1987: Francesco Di Raimondo; R LaPushin; Evan M Hersh
Synergism between alpha-interferon and interleukin-2-activated killer cells: in vitro studies.
Acta haematologica 1987;78 Suppl 1():77-83.
1987: J L Murray; D W Bywaters; James M Reuben; P W Mansell; Evan M Hersh
Decreased 5'-nucleotidase activity in suppressor (OKT8) T lymphocytes from homosexuals with AIDS-related complex: nonassociation with enhanced deoxynucleoside toxicity.
Clinical immunology and immunopathology 1987;42(1):10-7.
1986: R L Theriault; G N Hortobagyi; A U Buzdar; H B Levy; Evan M Hersh
Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
Cancer treatment reports 1986;70(11):1341-2.
1986: C V Sumaya; R N Boswell; Y Ench; D L Kisner; Evan M Hersh; James M Reuben; P W Mansell
Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex.
The Journal of infectious diseases 1986;154(5):864-70.
1986: J R Quesada; Evan M Hersh; J Manning; J Reuben; M Keating; E Schnipper; L Itri; Jordan U Gutterman
Treatment of hairy cell leukemia with recombinant alpha-interferon.
Blood 1986;68(2):493-7.
1986: G N Hortobagyi; Evan M Hersh; Nicholas E Papadopoulos; D Frye; A Rios; J M Reuben; Carl Plager; M Rosenblum; J Quesada
Initial clinical studies with copovithane.
Journal of biological response modifiers 1986;5(4):319-29.
1986: Y Z Patt; Evan M Hersh; J Reuben; L Claghorn; G Mavligit
A phase I study of intravenous azimexon therapy in human cancer.
Journal of biological response modifiers 1986;5(4):313-8.
1986: A Rios; D A Stringfellow; F A Fitzpatrick; S B Reele; G D Gutknecht; Evan M Hersh
Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients.
Journal of biological response modifiers 1986;5(4):330-8.
1986: R Kurzrock; J R Quesada; Moshe Talpaz; Evan M Hersh; J M Reuben; S A Sherwin; Jordan U Gutterman
Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(7):1101-9.
1986: Y Z Patt; G M Mavligit; J Reuben; P W Mansell; S Li; G Newell; Moshe Talpaz; Evan M Hersh
Modulation in vitro of immune parameters in homosexual males with the preclinical complex of symptoms related to acquired immune deficiency syndrome by azimexon.
Journal of biological response modifiers 1986;5(3):263-9.
1986: J Turpin; Evan M Hersh; G Lopez-Berestein
Characterization of small and large human peripheral blood monocytes: effects of in vitro maturation on hydrogen peroxide release and on the response to macrophage activators.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(11):4194-8.
1986: J R Quesada; J U Gutterman; Evan M Hersh
Treatment of hairy cell leukemia with alpha interferons.
Cancer 1986;57(8 Suppl):1678-80.
1986: H E Savage; Roger Rossen; Evan M Hersh; R S Freedman; J M Bowen; C Plager
Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells.
Cancer research 1986;46(4 Pt 2):2127-33.
1986: J L Murray; J Dowd; Evan M Hersh
In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
Journal of biological response modifiers 1986;5(1):12-9.
1986: M G Rosenblum; A M Rios; Evan M Hersh
Clinical pharmacology of the biological response modifier maleic anhydride divinyl ether copolymer (MVE-2).
Cancer chemotherapy and pharmacology 1986;18(3):243-6.
1986: PH Naylor; A Friedman-Kien; Evan M Hersh; M Erdos; allan l goldstein
Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum.
International journal of immunopharmacology 1986;8(7):667-76.
1986: Y Z Patt; P W Mansell; James M Reuben; L Claghorn; S Li; E Gehan; Evan M Hersh
Effect of azimexon therapy on host defense parameters and disease-associated symptoms in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC).
AIDS research 1986;2(3):191-209.
1986: G N Hortobagyi; A U Buzdar; G R Blumenschein; H Y Yap; Evan M Hersh
Prediction of survival by degree of reactivity to BCG in patients with metastatic breast cancer.
Developments in biological standardization 1986;58 ( Pt A)():357-63.
1986: K C Loftin; James M Reuben; W Dalton; Evan M Hersh; D Sujansky
Terminal transferase in leukemias by flow cytometry.
Diagnostic immunology 1986;4(3):165-9.
1986: J Turpin; Jeane Hester; Evan M Hersh; G Lopez-Berestein
Centrifugal elutriation as a method for isolation of large numbers of functionally intact human peripheral blood monocytes.
Journal of clinical apheresis 1986;3(2):111-8.
1986: J R Quesada; J Reuben; R L Hopfer; F K Mundon; Evan M Hersh
Serologic studies in hairy cell leukemia: high prevalence of Epstein-Barr and cytomegalovirus antibodies and absence of human T-cell lymphotrophic viruses antibodies.
Leukemia research 1986;10(10):1169-73.
1986: James M Reuben; J M LaRocco; C R Gschwind; C Stroud; A Rios; Evan M Hersh; P W Mansell
Relationship of exposure to human T lymphotropic virus and T helper cells in homosexual men.
AIDS research 1986;2(2):117-26.
1986: J L Murray; Roman Perez-Soler; D Bywaters; Evan M Hersh
Decreased adenosine deaminase (ADA) and 5'nucleotidase (5NT) activity in peripheral blood T cells in Hodgkin disease.
American journal of hematology 1986;21(1):57-66.
1985: Z Krizan; James L Murray; Evan M Hersh; Michael G Rosenblum; H J Glenn; C R Gschwind; Dennis J Carlo
Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.
Cancer research 1985;45(10):4904-9.
1985: A R Zander; J M Reuben; D Johnston; L Vellekoop; K A Dicke; J C Yau; Evan M Hersh
Immune recovery following allogeneic bone marrow transplantation.
Transplantation 1985;40(2):177-83.
1985: Roman Perez-Soler; G Lopez-Berestein; L P Kasi; F Cabanillas; M Jahns; H Glenn; Evan M Hersh; T Haynie
Distribution of technetium-99m-labeled multilamellar liposomes in patients with Hodgkin's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(7):743-9.
1985: M G Rosenblum; B W Unger; J U Gutterman; Evan M Hersh; G S David; J M Frincke
Modification of human leukocyte interferon pharmacology with a monoclonal antibody.
Cancer research 1985;45(6):2421-4.
1985: J L Murray; K C Loftin; C G Munn; James M Reuben; P W Mansell; Evan M Hersh
Elevated adenosine deaminase and purine nucleoside phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome.
Blood 1985;65(6):1318-24.
1985: Michael G Rosenblum; James L Murray; T P Haynie; H J Glenn; M F Jahns; Robert S Benjamin; J M Frincke; Dennis J Carlo; Evan M Hersh
Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
Cancer research 1985;45(5):2382-6.
1985: Roman Perez-Soler; G Lopez-Berestein; F Cabanillas; P McLaughlin; Evan M Hersh
Superoxide anion (O-2) production by peripheral blood monocytes in Hodgkin's disease and malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(5):641-5.
1985: G R Newell; P W Mansell; M R Spitz; James M Reuben; Evan M Hersh
Volatile nitrites. Use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome.
The American journal of medicine 1985;78(5):811-6.
1985: G Lopez-Berestein; V Fainstein; R Hopfer; K Mehta; M P Sullivan; M Keating; M G Rosenblum; R Mehta; M Luna; Evan M Hersh
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.
The Journal of infectious diseases 1985;151(4):704-10.
1985: J L Murray; Evan M Hersh; James M Reuben; C G Munn; P W Mansell
Abnormal lymphocyte response to exogenous interleukin-2 in homosexuals with acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC).
Clinical and experimental immunology 1985;60(1):25-30.
1985: A Rios; P W Mansell; G R Newell; James M Reuben; Evan M Hersh; J U Gutterman
Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferon.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(4):506-12.
1985: P Onali; Samuel J Strada; L Chang; P M Epstein; Evan M Hersh; W Joseph Thompson
Purification and characterization of high-affinity cyclic adenosine 5'-monophosphate phosphodiesterases from human acute myelogenous leukemic cells.
Cancer research 1985;45(3):1384-91.
1985: K C Loftin; James M Reuben; Evan M Hersh; D Sujansky
Cytoplasmic IgM in leukemic B cells by flow cytometry.
Leukemia research 1985;9(11):1379-87.
1985: G R Newell; P W Mansell; M B Wilson; H K Lynch; M R Spitz; Evan M Hersh
Risk factor analysis among men referred for possible acquired immune deficiency syndrome.
Preventive medicine 1985;14(1):81-91.
1985: J L Murray; James M Reuben; C G Munn; G Newell; P W Mansell; Evan M Hersh
In vitro modulation of purine enzyme metabolism and lymphocyte surface marker expression by thymosin fraction 5 in homosexual males.
International journal of immunopharmacology 1985;7(5):661-9.
1985: James M Reuben; Evan M Hersh; J L Murray; C G Munn; S R Mehta; P W Mansell
IL-2 production and response in vitro by the leukocytes of patients with acquired immune deficiency syndrome.
Lymphokine research 1985;4(2):103-16.
1985: Evan M Hersh; J U Gutterman; S Spector; H Friedman; S B Greenberg; James M Reuben; R LaPushin; M Matza; P W Mansell
Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
Cancer research 1985;45(1):406-10.
1984: J R Quesada; Evan M Hersh; J U Gutterman
Biologic therapy of hairy cell leukemia.
Seminars in oncology 1984;11(4 Suppl 2):507-10.
1984: Evan M Hersh; P W Mansell; James M Reuben; A Rios; G R Newell
Immunological characterizations of patients with acquired immune deficiency syndrome, acquired immune deficiency syndrome-related symptom complex, and a related life-style.
Cancer research 1984;44(12 Pt 1):5894-901.
1984: J M Reuben; Evan M Hersh
Delayed hypersensitivity responses of cancer patients to recall antigens using a new "Multitest" applicator.
Annals of allergy 1984;53(5):390-4.
1984: J L Murray; James M Reuben; C G Munn; P W Mansell; G R Newell; Evan M Hersh
Decreased 5' nucleotidase activity in lymphocytes from asymptomatic sexually active homosexual men and patients with the acquired immune deficiency syndrome.
Blood 1984;64(5):1016-21.
1984: A Y Bedikian; Y Z Patt; WK Murphy; T Umsawasadi; D T Carr; Evan M Hersh; Gerald P Bodey; Manuel Valdivieso
Prospective evaluation of thymosin fraction V immunotherapy in patients with non-small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapy.
American journal of clinical oncology 1984;7(5):399-404.
1984: G R Newell; S C Adams; P W Mansell; Evan M Hersh
Toxicity, immunosuppressive effects and carcinogenic potential of volatile nitrites: possible relationship to Kaposi's sarcoma.
Pharmacotherapy 1984;4(5):284-91.
1984: G Lopez-Berestein; R L Hopfer; R Mehta; K Mehta; Evan M Hersh; Rudy L Juliano
Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice.
The Journal of infectious diseases 1984;150(2):278-83.
1984: G Lopez-Berestein; L Milas; N Hunter; K Mehta; Evan M Hersh; C G Kurahara; M Vandupas; D A Eppstein
Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine.
Clinical & experimental metastasis 1984;2(2):127-37.
1984: G Lopez-Berestein; R L Hopfer; R Mehta; K Mehta; Evan M Hersh; Rudy L Juliano
Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B.
Antimicrobial agents and chemotherapy 1984;25(3):366-7.
1984: D J Stewart; T L Smith; M J Keating; K B McCredie; Evan M Hersh; J Quesada; E J Freireich
Prognostic factors in hairy cell leukemia (leukemic reticuloendotheliosis).
Cancer 1984;53(5):1198-1201.
1984: S D Pitlik; A Rios; Evan M Hersh; R Bolivar; P W Mansell
Polymicrobial brain abscess in a homosexual man with Kaposi's sarcoma.
Southern medical journal 1984;77(2):271-2.
1984: J R Quesada; J Reuben; J T Manning; Evan M Hersh; Jordan U Gutterman
Alpha interferon for induction of remission in hairy-cell leukemia.
The New England journal of medicine 1984;310(1):15-8.
1984: L P Kasi; G Lopez-Berestein; K Mehta; M Rosenblum; H J Glenn; T P Haynie; G Mavligit; Evan M Hersh
Distribution and pharmacology of intravenous 99mTc-labeled multilamellar liposomes in rats and mice.
International journal of nuclear medicine and biology 1984;11(1):35-7.
1984: C G Munn; James M Reuben; Evan M Hersh; P W Mansell; G R Newell
T cell surface antigen expression on lymphocytes of patients with AIDS during in vitro mitogen stimulation.
Cancer immunology, immunotherapy : CII 1984;18(3):141-8.
1984: G Lopez-Berestein; L Kasi; Michael G Rosenblum; T Haynie; M Jahns; H Glenn; R Mehta; G M Mavligit; Evan M Hersh
Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer.
Cancer research 1984;44(1):375-8.
1984: Evan M Hersh; James M Reuben; P W Mansell; A Rios; J U Gutterman; G Munn; J L Murray; S P Spector; A L Goldstein; G R Newell
Immunologic studies of the acquired immune deficiency syndrome: relationship of immunodeficiency to extent of disease.
Annals of the New York Academy of Sciences 1984;437():364-72.
1984: E Lotzová; C A Savary; Evan M Hersh; A A Khan; M Rosenblum
Depression of murine natural killer cell cytotoxicity by isobutyl nitrite.
Cancer immunology, immunotherapy : CII 1984;17(2):130-4.
1983: E Lotzová; C A Savary; J R Quesada; J U Gutterman; Evan M Hersh
Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Journal of the National Cancer Institute 1983;71(5):903-10.
1983: Y Sun; Evan M Hersh; Moshe Talpaz; S L Lee; W Wong; T L Loo; G M Mavligit
Immune restoration and/or augmentation of local graft versus host reaction by traditional Chinese medicinal herbs.
Cancer 1983;52(1):70-3.
1983: I Garcia; V Fainstein; A Rios; M Luna; P Mansell; J Reuben; Evan M Hersh
Nonbacterial thrombotic endocarditis in a male homosexual with Kaposi's sarcoma.
Archives of internal medicine 1983;143(6):1243-4.
1983: G Lopez-Berestein; R Mehta; R L Hopfer; K Mills; L Kasi; K Mehta; V Fainstein; M Luna; Evan M Hersh; Rudy L Juliano
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.
The Journal of infectious diseases 1983;147(5):939-45.
1983: L A Guarda; J J Butler; P Mansell; Evan M Hersh; J Reuben; G R Newell
Lymphadenopathy in homosexual men. Morbid anatomy with clinical and immunologic correlations.
American journal of clinical pathology 1983;79(5):559-68.
1983: G Lopez-Berestein; J Reuben; Evan M Hersh; R Kilbourn; J P Hester; M Bielski; Moshe Talpaz; G M Mavligit
Comparative functional analysis of lymphocytes and monocytes from plateletapheresis.
Transfusion 1983;23(3):201-6.
1983: S D Pitlik; V Fainstein; A Rios; L Guarda; P W Mansell; Evan M Hersh
Cryptosporidial cholecystitis.
The New England journal of medicine 1983;308(16):967.
1983: G Lopez-Berestein; K Mehta; R Mehta; Rudy L Juliano; Evan M Hersh
The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(4):1500-2.
1983: Evan M Hersh; P W Mansell; James M Reuben; J Frank; A Rios; R LaPushin; G Newell
Suppressor cell activity among the peripheral blood leukocytes of selected homosexual subjects.
Cancer research 1983;43(4):1905-9.
1983: A Rios; M Rosenblum; M Powell; Evan M Hersh
Phase I study of MVE-2 therapy in human cancer.
Cancer treatment reports 1983;67(3):239-43.
1983: Evan M Hersh; James M Reuben; H Bogerd; M Rosenblum; M Bielski; P W Mansell; A Rios; G R Newell; G Sonnenfeld
Effect of the recreational agent isobutyl nitrite on human peripheral blood leukocytes and on in vitro interferon production.
Cancer research 1983;43(3):1365-71.
1983: James M Reuben; Evan M Hersh; P W Mansell; G Newell; A Rios; R Rossen; A L Goldstein; J E McClure
Immunological characterization of homosexual males.
Cancer research 1983;43(2):897-904.
1983: M G Rosenblum; Evan M Hersh; T L Loo
Determination of the biological response modifier MVE-2 (AD-022) in biological fluids by high-performance liquid chromatography.
Journal of chromatography 1983;272(1):200-4.
1983: Evan M Hersh; James M Reuben; A Rios; P W Mansell; G R Newell; J E McClure; A L Goldstein
Elevated serum thymosin alpha 1 levels associated with evidence of immune dysregulation in male homosexuals with a history of infectious diseases or Kaposi's sarcoma.
The New England journal of medicine 1983;308(1):45-6.
1983: E Lotzová; C A Savary; J U Gutterman; J R Quesada; Evan M Hersh
Regulation of human natural killer cell cytotoxicity by recombinant leukocyte interferon clone A.
Journal of biological response modifiers 1983;2(5):482-96.
1983: Y Sun; Evan M Hersh; S L Lee; M McLaughlin; T L Loo; G M Mavligit
Preliminary observations on the effects of the Chinese medicinal herbs Astragalus membranaceus and Ligustrum lucidum on lymphocyte blastogenic responses.
Journal of biological response modifiers 1983;2(3):227-37.
1983: Evan M Hersh; James M Reuben; P W Mansell; A Rios; G R Newell; J Frank; A L Goldstein
Immunological studies of male homosexuals with the prodrome of the acquired immunodeficiency syndrome (AIDS).
Advances in experimental medicine and biology 1983;166():285-93.
1983: Roger Rossen; M M Crane; A C Morgan; E H Giannini; B C Giovanella; J S Stehlin; J J Twomey; Evan M Hersh
Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Cancer research 1983;43(1):422-9.
1983: G Lopez-Berestein; R Mehta; R Hopfer; K Mehta; Evan M Hersh; Rudy L Juliano
Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis.
Cancer drug delivery 1983;1(1):37-42.
1983: Evan M Hersh; P W Mansell; James M Reuben; A Rios; G R Newell; A L Goldstein; K Lynch
Leukocyte subset analysis and related immunological findings in acquired immunodeficiency disease syndrome (AIDS) and malignancies.
Diagnostic immunology 1983;1(3):168-73.
1983: P W Mansell; G R Newell; Evan M Hersh
The Acquired Immune Deficiency Syndrome.
Progress in clinical and biological research 1983;130():217-35.
1982: Lynn Feun; J Gutterman; M A Burgess; Evan M Hersh; G Mavligit; C M McBride; Robert S Benjamin; Stephen Richman; WK Murphy; Gerald P Bodey; B W Brown; C F Mountain; M E Leavens; E J Freireich
The natural history of resectable metastatic melanoma (Stage IVA melanoma).
Cancer 1982;50(8):1656-63.
1982: K Mehta; G Lopez-Berestein; Evan M Hersh; Rudy L Juliano
Uptake of liposomes and liposome-encapsulated muramyl dipeptide by human peripheral blood monocytes.
Journal of the Reticuloendothelial Society 1982;32(2):155-64.
1982: A Robidoux; J U Gutterman; Gerald P Bodey; Evan M Hersh
Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.
Cancer 1982;49(11):2246-51.
1982: E Lotzová; C A Savary; J U Gutterman; Evan M Hersh
Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.
Cancer research 1982;42(6):2480-8.
1982: C Wiseman; J M Jessup; T L Smith; Evan M Hersh; J Bowen; G Blumenshein
Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapy.
Cancer 1982;49(6):1266-71.
1982: Evan M Hersh; J Quesada; M J Keating; S Rasmussen; S G Murphy; C Gschwind; J Morgan
Host defence factors and prognosis in hairy cell leukemia.
Leukemia research 1982;6(5):625-37.
1982: J R Quesada; J U Gutterman; Evan M Hersh
Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer.
Journal of interferon research 1982;2(4):593-9.
1982: E Pihl; B Jansson; M A Schwartz; M A Malahy; J L Smith; J V Gutterman; Evan M Hersh
Germinal centre hyperplasia: an unfavourable immune response in recurrent malignant melanoma.
Pathology 1982;14(1):13-6.
1982: Moshe Talpaz; M Bielski; Evan M Hersh
Studies of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity among patients with acute leukemia in complete remission.
Cancer immunology, immunotherapy : CII 1982;14(2):96-8.
1982: Evan M Hersh; C Gschwind; D L Morris; S Murphy
Deficient strongly adherent monocytes in the peripheral blood of cancer patients.
Cancer immunology, immunotherapy : CII 1982;14(2):105-9.
1982: Evan M Hersh; J Quesada; S G Murphy; J U Gutterman; R D Hutchins
Evaluation of therapy with methanol extraction residue of BCG (MER).
Cancer immunology, immunotherapy : CII 1982;14(1):4-9.
1982: R K Oldham; M H Gail; M A Baker; J T Forbes; W Heineman; Evan M Hersh; Carmack Holmes; R E Ritts; P W Wright
Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer.
Cancer immunology, immunotherapy : CII 1982;13(3):164-73.
1982: L Milas; Evan M Hersh; D A Stringfellow; N Hunter
Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
Journal of the National Cancer Institute 1982;68(1):139-45.
1981: Manuel Valdivieso; T F Tenczynski; V Rodriguez; M A Burgess; C F Mountain; H T Barkley; Evan M Hersh; Gerald P Bodey
Chemoimmunotherapy of small cell bronchogenic carcinoma with VP-16-213, ifosfamide, vincristine, adriamycin, and Corynebacterium parvum.
Cancer 1981;48(2):238-44.
1981: G M Mavligit; R Benjamin; Yehuda Z Patt; N Jaffe; V Chuang; S Wallace; J Murray; A Ayala; S Johnston; Evan M Hersh; D B Calvo
Intraarterial cis-platinum for patients with inoperable skeletal tumors.
Cancer 1981;48(1):1-4.
1981: M J Keating; T L Smith; K B McCredie; Gerald P Bodey; Evan M Hersh; J U Gutterman; E Gehan; E J Freireich
A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia.
Cancer 1981;47(12):2779-88.
1981: L Milas; Evan M Hersh; N Hunter
Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
Cancer research 1981;41(6):2378-85.
1981: Evan M Hersh; S G Murphy; J R Quesada; J U Gutterman; C R Gschwind; J Morgan
Effect of immunotherapy with Corynebacterium parvum and methanol extraction residue of BCG administered intravenously on host defense function in cancer patients.
Journal of the National Cancer Institute 1981;66(6):993-1002.
1981: G M Mavligit; D B Calvo; Y Z Patt; Evan M Hersh
Immune restoration and/or augmentation of local xenogeneic graft versus host reaction by Cimetidine in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(6):2272-4.
1981: Janardan P Pandey; A H Johnson; H H Fudenberg; D B Amos; J U Gutterman; Evan M Hersh
HLA antigens and immunoglobulin allotypes in patients with malignant melanoma.
Human immunology 1981;2(3):185-90.
1981: Stephen Richman; Evan M Hersh; J U Gutterman; G N Hortobagyi; G R Blumenschein; A Rios; E Ribi
Administration of BCG cell wall skeleton into malignant effusions: toxic and therapeutic effects.
Cancer treatment reports 1981;65(5-6):383-7.
1981: Gerald P Bodey; E J Freireich; K B McCredie; T L Smith; E A Gehan; J U Gutterman; Evan M Hersh
Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy.
Cancer 1981;47(8):1937-45.
1981: G N Hortobagyi; T L Smith; kenneth d swenerton; Sewa S Legha; A U Buzdar; G R Blumenschein; J U Gutterman; Evan M Hersh
Prognostic value of prechemotherapy skin tests in patients with metastatic breast carcinoma.
Cancer 1981;47(6):1369-76.
1981: S Wallace; V P Chuang; D Swanson; B Bracken; Evan M Hersh; A Ayala; D Johnson
Embolization of renal carcinoma.
Radiology 1981;138(3):563-70.
1981: Y Z Patt; V P Chuang; S Wallace; Evan M Hersh; E J Freireich; G M Mavligit
The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic to the liver.
Lancet 1981;1(8216):349-50.
1981: C H Granatek; K Ezaki; Evan M Hersh; M J Keating; S Rasmussen
Antibody responses of remission leukemia patients receiving active specific and nonspecific immunotherapy.
Cancer 1981;47(2):272-9.
1981: R D Snyder; G N Hortobagyi; Gerald P Bodey; J U Gutterman; Evan M Hersh
Combination therapy for advanced malignant melanoma with BCNU, pseudomonas vaccine, and heparin.
Journal of surgical oncology 1981;16(1):87-92.
1981: H Toki; Evan M Hersh; S Murphy; H Glenn; T P Haynie; R A White
Use of mini-microaggregated albumin to study reticuloendothelial system (RES) function in C. parvum-treated animals.
International journal of immunopharmacology 1981;3(2):147-52.
1981: H Toki; Evan M Hersh; J U Gutterman; T P Haynie; H Glenn; R A White; A Rios
Organ distributions and clearance studies of 99mtechnetium-labeled Corynebacterium parvum in patients with leukemia.
International journal of immunopharmacology 1981;3(2):141-5.
1981: J R Quesada; Evan M Hersh; M Keating; A Zander; J Hester
Hairy cell leukemia: clinical effects of the methanol extraction residue (MER) of BCG, lithium carbonate and mononuclear cell-enriched leukocyte transfusions.
Leukemia research 1981;5(6):463-76.
1980: U H Lewinski; G M Mavligit; Evan M Hersh
Cellular immune modulation after a single high dose of Levamisole in patients with carcinoma.
Cancer 1980;46(10):2185-94.
1980: U H Lewinski; G M Mavligit; P M Epstein; Evan M Hersh; R A Ortez; W J Thompson
Cyclic nucleotide alterations in mixed leukocyte reaction: a preliminary report.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1980;33(7):217-9.
1980: Stephen Richman; J U Gutterman; Evan M Hersh
Chemotherapy and immunotherapy for malignant melanoma.
Comprehensive therapy 1980;6(10):57-61.
1980: Evan M Hersh; S Murphy; A Zander; K Dicke; D J Stewart; H Toki; J Latreille
Host defense deficiency in hairy cell leukemia and its correction by leukocyte transfusion.
Blood 1980;56(3):526-33.
1980: Evan M Hersh; Y Z Patt; S G Murphy; K Dicke; A Zander; M Adegbite; R Goldman
Radiosensitive, thymic hormone-sensitive peripheral blood suppressor cell activity in cancer patients.
Cancer research 1980;40(9):3134-40.
1980: J U Gutterman; G R Blumenschein; R Alexanian; H Y Yap; A U Buzdar; F Cabanillas; G N Hortobagyi; Evan M Hersh; S L Rasmussen; M Harmon; M Kramer; S Pestka
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.
Annals of internal medicine 1980;93(3):399-406.
1980: V R Lavis; Samuel J Strada; C P Ross; Evan M Hersh; W Joseph Thompson
Comparison of the responses of freshly isolated and cultured human monocytes and P388D1 cells to agents affecting cyclic AMP metabolism.
The Journal of laboratory and clinical medicine 1980;96(3):551-61.
1980: A Y Bedikian; Manuel Valdivieso; J Maroun; J U Gutterman; Evan M Hersh; Gerald P Bodey
Evaluation of vindesine and MER in colorectal cancer.
Cancer 1980;46(3):463-7.
1980: Y Z Patt; G M Mavligit; V P Chuang; S Wallace; S Johnston; R S Benjamin; Manuel Valdivieso; Evan M Hersh
Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
Cancer 1980;46(2):261-5.
1980: W Joseph Thompson; C P Ross; Samuel J Strada; Evan M Hersh; V R Lavis
Comparative analyses of cyclic adenosine 3':5'-monophosphate phosphodiesterases of human peripheral blood monocytes and cultured P388D1 cells.
Cancer research 1980;40(6):1955-60.
1980: M A Schwarz; J U Gutterman; M A Burgess; Lance K Heilbrun; W K Murphy; Gerald P Bodey; E Stone; V Turner-Chism; Evan M Hersh
Chemoimmunotherapy of disseminated malignant melanoma with DTIC-BCG, transfer factor + melphalan.
Cancer 1980;45(10):2506-15.
1980: M J Keating; T L Smith; E A Gehan; K B McCredie; Gerald P Bodey; G Spitzer; Evan M Hersh; J Gutterman; E J Freireich
Factors related to length of complete remission in adult acute leukemia.
Cancer 1980;45(8):2017-29.
1980: J R Quesada; H I Libshitz; Evan M Hersh; J U Gutterman
Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of Bacillus Calmette-Guerin.
Cancer 1980;45(6):1340-3.
1980: D B Calvo; Yehuda Z Patt; S Wallace; V P Chuang; Robert S Benjamin; J D Pritchard; Evan M Hersh; Gerald P Bodey; G M Mavligit
Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy.
Cancer 1980;45(6):1278-83.
1980: C L Wiseman; J M Bowen; J W Davis; Evan M Hersh; B W Brown; G R Blumenschein
Human lymphocyte blastogenesis responses to mouse mammary tumor virus.
Journal of the National Cancer Institute 1980;64(3):425-30.
1980: G R Blumenschein; G N Hortobagyi; Stephen Richman; J U Gutterman; C K Tashima; A U Buzdar; M A Burgess; R B Livingston; Evan M Hersh
Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.
Cancer 1980;45(4):742-9.
1980: P M Epstein; J S Mills; Evan M Hersh; Samuel J Strada; W Joseph Thompson
Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents.
Cancer research 1980;40(2):379-86.
1980: G N Hortobagyi; H Y Yap; C L Wiseman; G R Blumenschein; A U Buzdar; Sewa S Legha; J U Gutterman; Evan M Hersh; Gerald P Bodey
Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine.
Cancer treatment reports 1980;64(1):157-9.
1980: W Joseph Thompson; C P Ross; Evan M Hersh; P M Epstein; Samuel J Strada
Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
Journal of cyclic nucleotide research 1980;6(1):25-36.
1979: A Rios; Evan M Hersh; J U Gutterman; G M Mavligit; H Schimek; J E McEntire; B W Papermaster
The use of leukocyte cell line culture supernatant for skin reaction testing in malignant melanoma.
Cancer 1979;44(5):1615-21.
1979: J A Maroun; J R Quesada; Evan M Hersh; J U Gutterman; Stephen Richman; M A Schwarz; N Parker
Phase I toxicity study of methanol-extracted residue of Bacillus Calmette-Guérin by the iv route.
Cancer treatment reports 1979;63(11-12):1781-6.
1979: G N Hortobagyi; J U Gutterman; G R Blumenschein; C K Tashima; M A Burgess; L Einhorn; A U Buzdar; Stephen Richman; Evan M Hersh
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Cancer 1979;44(5):1955-62.
1979: A U Buzdar; G R Blumenschein; J U Gutterman; C K Tashima; G N Hortobagyi; T L Smith; L T Campos; W L Wheeler; Evan M Hersh; E J Freireich; E A Gehan
Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.
JAMA : the journal of the American Medical Association 1979;242(14):1509-13.
1979: U H Lewinski; G M Mavligit; W J Thompson; Evan M Hersh; R A Ortez
Immunotherapy with levamisole: early decrease of cAMP levels in lymphocytes from treated cancer patients.
Cancer 1979;44(4):1280-3.
1979: G N Hortobagyi; G R Blumenschein; C K Tashima; A U Buzdar; M A Burgess; R B Livingston; Manuel Valdivieso; J U Gutterman; Evan M Hersh; Gerald P Bodey
Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.
Cancer 1979;44(2):398-405.
1979: Evan M Hersh; J U Gutterman; C M McBride
Combined modality therapy of malignant melanoma.
World journal of surgery 1979;3(3):329-43.
1979: E S Rivera; Evan M Hersh; J M Bowen; J W Barnett; T Wharton; S G Murphy
Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
Cancer 1979;43(6):2297-305.
1979: G N Hortobagyi; J U Gutterman; G R Blumenschein; C K Tashima; M A Burgess; L Einhorn; A U Buzdar; Stephen Richman; Evan M Hersh
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Cancer 1979;43(4):1225-33.
1979: G N Hortobagyi; J U Gutterman; G R Blumenschein; H Y Yap; A U Buzdar; C K Tashima; M A Burgess; Evan M Hersh
Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
Cancer 1979;43(3):1112-22.
1979: Stephen Richman; J U Gutterman; Evan M Hersh
Cancer immunotherapy.
Canadian Medical Association journal 1979;120(3):322-4, 329.
1979: D L Morris; Evan M Hersh; B P Hsi; J U Gutterman; M M Marshall; G M Mavligit
Recall antigen delayed-type hypersensitivity skin testing in melanoma and acute leukemia patients and their associates.
Cancer research 1979;39(1):219-26.
1979: A U Buzdar; G R Blumenschein; T L Smith; C K Tashima; G N Hortobagyi; H Y Yap; J U Gutterman; Evan M Hersh; E A Gehan
Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
Journal of surgical oncology 1979;12(1):27-40.
1979: A U Buzdar; Sewa S Legha; C K Tashima; H Y Yap; G N Hortobagyi; Evan M Hersh; G R Blumenschein; Gerald P Bodey
Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.
Cancer treatment reports 1979;63(1):115-20.
1979: Roger Rossen; M A Reisberg; D Singer; W N Suki; J Duffy; Evan M Hersh; F X Schloeder; L L Hill; G Eknoyan
The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
Medicine 1979;58(1):65-79.
1979: A N Krutchik; A U Buzdar; G R Blumenschein; G N Hortobagyi; C K Tashima; J U Gutterman; H Y Yap; Evan M Hersh
Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.
Journal of surgical oncology 1979;11(4):325-32.
1979: Y Z Patt; Evan M Hersh; M Adebite; R Goldman; G Mavligit
New approaches to the evaluation of immunomodulation by thymic hormones.
Annals of the New York Academy of Sciences 1979;332():160-71.
1978: Y Z Patt; S Wallace; Evan M Hersh; S W Hall; Y B Menachem; M Granmayeh; C M McBride; R S Benjamin; G M Mavligit
Hepatic arterial infusion of Corynebacterium parvum and chemotherapy.
Surgery, gynecology & obstetrics 1978;147(6):897-902.
1978: G N Hortobagyi; H Y Yap; G R Blumenschein; J U Gutterman; A U Buzdar; C K Tashima; Evan M Hersh
Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
Cancer treatment reports 1978;62(11):1685-92.
1978: G N Hortobagyi; Stephen Richman; K Dandridge; J U Gutterman; G R Blumenschein; Evan M Hersh
Immunotherapy with BCG administered by scarification: standardization of reactions and management of side effects.
Cancer 1978;42(5):2293-303.
1978: Y Z Patt; Evan M Hersh; K Dicke; G Spitzer; G M Mavligit
Suppressor cell activity in cancer patients: a possible role for thymic hormones.
Cancer treatment reports 1978;62(11):1763-8.
1978: G M Dosik; J U Gutterman; Evan M Hersh; M Akhtar; T Sonoda; R G Horn
Nephrotoxicity from cancer immunotherapy.
Annals of internal medicine 1978;89(1):41-6.
1978: B F Issell; Manuel Valdivieso; Evan M Hersh; Stephen Richman; J U Gutterman; Gerald P Bodey
Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Cancer treatment reports 1978;62(7):1059-63.
1978: P S Ritch; K B McCredie; J U Gutterman; Evan M Hersh
Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia.
Cancer 1978;42(1):167-70.
1978: S Murphy; Evan M Hersh
Immunotherapy of leukemia and lymphoma.
Seminars in hematology 1978;15(2):181-203.
1978: R A Ortez; Evan M Hersh; G A Robison
Loss of lymphocyte cyclic AMP dependent protein kinase activity in malignant melanoma.
Journal of cyclic nucleotide research 1978;4(2):87-96.
1978: A U Buzdar; J U Gutterman; G R Blumenschein; G N Hortobagyi; C K Tashima; T L Smith; Evan M Hersh; E J Freireich; E A Gehan
Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.
Cancer 1978;41(3):1064-75.
1978: Roger Rossen; R H Zubler; N K Day; M A Reisberg; A C Morgan; J U Gutterman; Evan M Hersh
Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
The Journal of laboratory and clinical medicine 1978;91(2):191-204.
1978: J U Gutterman; Stephen Richman; C M McBride; M A Burgess; S L Bartold; A Kennedy; E A Gehan; G Mavligit; Evan M Hersh
Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1978;68():359-62.
1978: J C Bottino; Roger Rossen; Evan M Hersh; A Rios; J P Hester; C M McBride
Response of malignant melanoma to plasma exchange, surgical debulking, and Corynebacterium parvum.
The International journal of artificial organs 1978;1(1):53-7.
1978: Evan M Hersh
Evaluation of immunocompetence in cancer patients.
The Laryngoscope 1978;88(1 Pt 2 Suppl 8):19-20.
1978: A V Buzdar; J U Gutterman; G R Blumenschein; C K Tashima; G N Hortobágyi; H Y Yap; Evan M Hersh; E A Gehan
Adjuvant therapy of stage II, III breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1978;68():123-8.
1978: G M Mavligit; Evan M Hersh
In vitro antitumor reactivity of mononuclear leukocytes from cancer patients receiving immunotherapy with BCG.
Medical and pediatric oncology 1978;5(1):115-26.
1978: K Ezaki; Evan M Hersh; M Keating; S Dyre; A Hollinshead; K B McCredie; G M Mavlight; J U Gutterman
Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia.
Cancer 1978;41(1):70-83.
1977: Roger Rossen; Evan M Hersh; J T Sharp; K B McCredie; F Gyorkey; W N Suki; G Eknoyan; M A Reisberg
Effect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisone.
The American journal of medicine 1977;63(5):674-82.
1977: G M Mavligit; J U Gutterman; M A Malahy; M A Burgess; C M McBride; A Jubert; Evan M Hersh
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival.
Cancer 1977;40(5 Suppl):2726-30.
1977: E Pihl; M A Malahy; N Khankhanian; Evan M Hersh; G M Mavligit
Immunomorphological features of prognostic significance in Dukes' Class B colorectal carcinoma.
Cancer research 1977;37(11):4145-9.
1977: Manuel Valdivieso; A Bedikian; M A Burgess; V Rodriguez; Evan M Hersh; Gerald P Bodey; G M Mavligit
Chemoimmunotherapy of metastatic large bowel cancer: nonspecific stimulation with BCG and levamisole.
Cancer 1977;40(5 Suppl):2731-9.
1977: P M Epstein; J S Mills; C P Ross; S J Strada; Evan M Hersh; W J Thompson
Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
Cancer research 1977;37(11):4016-23.
1977: Joseph Cotropia; J U Gutterman; Evan M Hersh; G M Mavligit
Surface immunoglobulins and protease inhibitors of human acute leukemia blasts.
International journal of cancer. Journal international du cancer 1977;20(4):520-31.
1977: J Y Suen; Stephen Richman; R B Livingston; Evan M Hersh; R Craig; K Tonymon
Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck.
American journal of surgery 1977;134(4):474-8.
1977: C H Granatek; Evan M Hersh; J U Gutterman; G M Mavligit
Tumor-related blocking of anti-fetal immunity.
European journal of cancer 1977;13(9):999-1007.
1977: M A Schwarz; J U Gutterman; Evan M Hersh; Stephen Richman; G M Mavligit
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.
World journal of surgery 1977;1(5):555-83.
1977: Stephen Richman; J U Gutterman; Evan M Hersh; M A Burgess; G M Mavligit
Phase I study of immunotherapy with methanol extraction residue (MER) of bacillus Calmette-Guérin.
Cancer treatment reports 1977;61(3):471-2.
1977: Roger Rossen; M A Reisberg; Evan M Hersh; J U Gutterman
The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.
Journal of the National Cancer Institute 1977;58(5):1205-15.
1977: U H Lewinski; G M Mavlight; J U Gutterman; Evan M Hersh
Interaction between repeated skin testing with recall antigens and temporal fluctuations of in vitro lymphocyte blastogenesis in cancer patients.
Clinical immunology and immunopathology 1977;7(1):77-84.
1977: E M McKelvey; J K Luce; R W Talley; Evan M Hersh; J S Hewlett; T E Moon
Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
Cancer 1977;39(1):1-4.
1977: G N Hortobagyi; J U Gutterman; G R Blumenschein; A Buzdar; M A Burgess; Stephen Richman; C K Tashima; M Schwarz; Evan M Hersh
Chemo immunotherapy of advanced breast cancer with BCG.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1977;(62):143-50.
1977: M J Keating; E J Freireich; K B McCredie; Gerald P Bodey; Evan M Hersh; J P Hester; V Rodriguez; J Hart
Acute leukemia in adults, 1977.
CA: a cancer journal for clinicians 1977;27(1):2-25.
1977: Evan M Hersh; J U Gutterman; G M Mavligit
BCG as adjuvant immunotherapy for neoplasia.
Annual review of medicine 1977;28():489-515.
1977: R L Banner; W K Vaughn; K A Hagey; W J Thompson; Evan M Hersh
Cyclic adenosine monophosphate-phosphodiesterase (cAMP-PDE) in lymphocytes from patients with stage III and IV squamous cell carcinoma of the head and neck.
Journal of surgical oncology 1977;9(1):61-9.
1977: Evan M Hersh; J U Gutterman; G M Mavligit
Immunotherapy of human cancer.
Advances in internal medicine 1977;22():145-85.
1976: E J Freireich; Gerald P Bodey; K B McCredie; Evan M Hersh; E A Gehan; J Hart; J U Gutterman; V Rodriguez; T Smith; J P Hester
Developmental therapy in adult acute leukemia.
Archives of internal medicine 1976;136(12):1417-21.
1976: J U Gutterman; J O Cardenas; G R Blumenschein; G Hortobagyi; M A Burgess; R B Livingston; G M Mavligit; E J Freireich; J A Gottlieb; Evan M Hersh
Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
British medical journal 1976;2(6046):1222-5.
1976: H Biran; J L Moake; R C Reed; J U Gutterman; Evan M Hersh; E J Freireich; G M Mavligit
Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.
British journal of cancer 1976;34(5):493-9.
1976: P Minden; C Jarrett; J K McClatchy; J U Gutterman; Evan M Hersh
Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients.
Nature 1976;263(5580):774-7.
1976: Evan M Hersh; G M Mavligit; J U Gutterman
Immunological evaluation of malignant disease. Diagnosis, prognosis, and management.
JAMA : the journal of the American Medical Association 1976;236(15):1739-42.
1976: G M Mavligit; J U Gutterman; Evan M Hersh
Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma.
Journal of the National Cancer Institute 1976;57(4):749-51.
1976: C H Granatek; M G Hanna; Evan M Hersh; J U Gutterman; G M Mavligit; E L Candler
Fetal antigens in human leukemia.
Cancer research 1976;36(9 PT 2):3464-70.
1976: Evan M Hersh; J U Gutterman; G M Mavligit
Immunotherapy of leukemia.
The Medical clinics of North America 1976;60(5):1019-42.
1976: W J Thompson; C P Ross; Warren Pledger; S J Strada; R L Banner; Evan M Hersh
Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes.
The Journal of biological chemistry 1976;251(16):4922-9.
1976: D Farquhar; T L Loo; J U Gutterman; Evan M Hersh; M A Luna
Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment.
Biochemical pharmacology 1976;25(13):1529-35.
1976: B Drewinko; G M Mavligit; U Ambus; Evan M Hersh
Inhibition of human lymphoma cell-line colony formation by lymphocytes from patients with lymphoma and cancer hospital employees.
Cancer 1976;37(6):2929-37.
1976: J U Gutterman; G M Mavligit; Evan M Hersh
Chemoimmunotherapy of human solid tumors.
The Medical clinics of North America 1976;60(3):441-62.
1976: Evan M Hersh; G M Mavligit; J U Gutterman
Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient.
The Medical clinics of North America 1976;60(3):623-39.
1976: M G Hanna; L C Peters; J U Gutterman; Evan M Hersh
Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pig.
Journal of the National Cancer Institute 1976;56(5):1013-7.
1976: Stephen Richman; R B Livingston; J U Gutterman; J Y Suen; Evan M Hersh
Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized study.
Cancer treatment reports 1976;60(5):535-9.
1976: G M Mavligit; J U Gutterman; M A Burgess; N Khankhanian; G B Seibert; J F Speer; A V Jubert; R C Martin; C M McBride; E M Copeland; E A Gehan; Evan M Hersh
Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil.
Lancet 1976;1(7965):871-6.
1976: Roger Rossen; J Duffy; K B McCredie; M A Reisberg; J T Sharp; Evan M Hersh; G Eknoyan; W N Suki
Treatment of Goodpasture syndrome with cyclophosphamide, prednisone and plasma exchange transfusions.
Clinical and experimental immunology 1976;24(1):218-22.
1976: Evan M Hersh; J U Gutterman; G M Mavligit
Assessment of immunocompetence in the routine evaluation of the cancer patient.
Southern medical journal 1976;69(3):356-9.
1976: Evan M Hersh; J U Gutterman; G M Mavligit
Anergy in cancer.
International journal of dermatology 1976;15(2):112-20.
1976: J U Gutterman; G M Mavligit; R Reed; M A Burgess; J Gottlieb; Evan M Hersh
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Cancer treatment reports 1976;60(2):177-82.
1976: J U Gutterman; G M Mavligit; G Blumenshein; M A Burgess; C M McBride; Evan M Hersh
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
Annals of the New York Academy of Sciences 1976;277(00):135-59.
1976: Evan M Hersh; G M Mavligit; J U Gutterman; P B Barsales
Mononuclear cell content of human solid tumors.
Medical and pediatric oncology 1976;2(1):1-9.
1976: R Garcia-Rinaldi; Roger Rossen; Evan M Hersh; L Kormeier; W T Butler
Specific in vitro binding of radiolabeled antibodies to cell surface antigens: interaction of antihuman thymocyte globulin with human target cells.
Journal of immunological methods 1976;9(3-4):235-49.
1976: Evan M Hersh; J U Gutterman; G M Mavligit; C W Mountain; C M McBride; M A Brugess; P M Lurie; Marvin Zelen; H Takita; R G Vincent
Immunocompetence, immunodeficiency and prognosis in cancer.
Annals of the New York Academy of Sciences 1976;276():386-406.
1976: L A Schafer; A L Goldstein; J U Gutterman; Evan M Hersh
In vitro and in vivo studies with thymosin in cancer patients.
Annals of the New York Academy of Sciences 1976;277(00):609-20.
1976: Joseph Cotropia; J U Gutterman; Evan M Hersh; C H Granatek; G M Mavligit
Antigen expression and cell surface properties of human leukemic blasts.
Annals of the New York Academy of Sciences 1976;276():146-64.
1975: Stephen Richman; G M Mavligit; R Wolk; J U Gutterman; Evan M Hersh
Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.
JAMA : the journal of the American Medical Association 1975;234(12):1233-5.
1975: G M Mavligit; J U Gutterman; M A Burgess; N Khankhanian; G B Seibert; J F Speer; R C Reed; A V Jubert; R C Martin; C M McBride; E M Copeland; E A Gehan; Evan M Hersh
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results.
Cancer 1975;36(6 Suppl):2421-7.
1975: G M Mavligit; P B Barsales; J U Gutterman; B Mackay; Evan M Hersh
A rapid method for establishing short-term primary cultures of human tumor cells from fresh tumor biopsies.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1975;150(3):597-601.
1975: Gerald P Bodey; Evan M Hersh; Manuel Valdivieso; R Feid; V Rodriguez
Effects of cytotoxic and immunosuppressive agents on the immune system.
Postgraduate medicine 1975;58(7):67-74.
1975: L A Schaffer; J U Gutterman; G M Mavligit; R C Reed; Evan M Hersh
Permanent slide preparations of T lymphocyte-sheep red blood cell rosettes.
Journal of immunological methods 1975;8(3):241-9.
1975: Evan M Hersh; E J Freireich; E Frei; D Hammond
Myron r. karon--a tribute.
Cancer research 1975;35(8):2220-1.
1975: Evan M Hersh; J U Gutterman; G M Mavligit; R C Reed
Role of BCG immunotherapy in malignant disease.
Southern medical journal 1975;68(6):673-5.
1975: J U Gutterman; G Mavligit; R Reed; Stephen Richman; C E McBride; Evan M Hersh
Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
Seminars in oncology 1975;2(2):155-74.
1975: G M Mavligit; A Jubert; J U Gutterman; R C Reed; Evan M Hersh
Subpopulations of thymus dependent and thymus independent lymphocytes in human gut associated lymphoid tissues.
Surgery, gynecology & obstetrics 1975;140(3):397-400.
1975: F G Gercovich; J U Gutterman; G M Mavligit; Evan M Hersh
Active specific immunization in malignant melanoma.
Medical and pediatric oncology 1975;1(3):277-87.
1975: Evan M Hersh
Cancer immunology.
Transactions & studies of the College of Physicians of Philadelphia 1975;42(3):234-6.
1975: Evan M Hersh; J U Gutterman; G M Mavligit
Cancer and host defense mechanisms.
Pathobiology annual 1975;5():133-67.
1974: J U Gutterman; G M Mavligit; R C Reed; Evan M Hersh
Letter: Treatment of malignant melanoma.
Lancet 1974;2(7894):1460.
1974: J U Gutterman; Evan M Hersh; V Rodriguez; K B McCredie; G Mavligit; R Reed; M A Burgess; T Smith; E Gehan; Gerald P Bodey; E J Freireich
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.
Lancet 1974;2(7894):1405-9.
1974: J U Gutterman; G M Mavligit; R C Reed; Evan M Hersh
Immunochemotherapy of human cancer.
Seminars in oncology 1974;1(4):409-23.
1974: L C Peters; M G Hanna; J V Gutterman; G M Mavligit; Evan M Hersh
Modulation of the immune response of guinea pigs by repeated BCG scarification.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1974;147(2):344-9.
1974: G M Mavligit; Evan M Hersh; C M McBride
Lymphocyte blastogenesis induced by autochthonous human solid tumor cells: relationship to stage of disease and serum factors.
Cancer 1974;34(5):1712-21.
1974: G M Mavligit; J U Guttermann; M A Burgess; J F Speer; R C Reed; R C Martin; C M McBride; E M Copeland; E A Gehan; Evan M Hersh
Immunotherapy: its possible application in the management of large-bowel cancer.
The American journal of digestive diseases 1974;19(11):1047-53.
1974: G M Mavligit; J U Gutterman; Evan M Hersh; R Alexanian
Cell-mediated immunity to plasma cell myeloma: specific inhibition by a serum factor adhering to effector lymphocytes.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1974;147(2):537-40.
1974: L Milas; J U Gutterman; I Basic; N Hunter; G M Mavligit; Evan M Hersh; H R Withers
Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
International journal of cancer. Journal international du cancer 1974;14(4):493-503.
1974: J U Gutterman; G Mavligit; J A Gottlieb; M A Burgess; C E McBride; L Einhorn; E J Freireich; Evan M Hersh
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
The New England journal of medicine 1974;291(12):592-7.
1974: U Ambus; G M Mavlight; J U Gutterman; C M McBride; Evan M Hersh
Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy.
International journal of cancer. Journal international du cancer 1974;14(3):291-300.
1974: Evan M Hersh; G M Mavligit; J U Gutterman
Immunotherapy as related to lung cancer: a review.
Seminars in oncology 1974;1(3):273-8.
1974: G M Mavligit; A V Jubert; J U Gutterman; C M McBride; Evan M Hersh
Immune reactivity of lymphoid tissues adjacent to carcinoma of the ascending colon.
Surgery, gynecology & obstetrics 1974;139(3):409-12.
1974: Evan M Hersh; M G Hanna; J U Gutterman; G Mavligit; M Yurconic; C R Gschwind
Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunity.
Journal of the National Cancer Institute 1974;53(2):327-33.
1974: L H Einhorn; M A Burgess; C Vallejos; Gerald P Bodey; J Gutterman; G Mavligit; Evan M Hersh; J K Luce; E Frei; E J Freireich; J A Gottlieb
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.
Cancer research 1974;34(8):1995-2004.
1974: Evan M Hersh; J U Gutterman; G M Mavligit; K B McCredie; M A Burgess; A Matthews; E J Freireich
Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
The Journal of clinical investigation 1974;54(2):401-8.
1974: J U Gutterman; G Mavligit; M A Burgess; K B McCredie; C Hunter; E J Freireich; Evan M Hersh
Immunodiagnosis of acute leukemia: detection of residual disease.
Journal of the National Cancer Institute 1974;53(2):389-92.
1974: Evan M Hersh; J U Gutterman; G Mavligit; C R Gschwind; E J Freireich; P H Levine; E J Plata
Human immune response to active immunization with Rauscher leukemia virus. I. Cell-mediated and cell-associated immunity.
Journal of the National Cancer Institute 1974;53(2):317-25.
1974: Evan M Hersh; E J Freireich
Editorial: Focus on cutaneous host-defense failure in transplant recipients.
JAMA : the journal of the American Medical Association 1974;229(4):457-8.
1974: Evan M Hersh; K B McCredie; E J Freireich
Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts.
Clinical and experimental immunology 1974;17(3):463-73.
1974: Evan M Hersh; S E Dyre
Cells binding the antigen keyhole limpet haemocyanin in the peripheral blood and in the lymphocyte cultures of non-immune and immunized human subjects.
Clinical and experimental immunology 1974;17(2):299-309.
1974: R C Reed; J U Gutterman; G M Mavlight; Evan M Hersh
Sialic acid on leukemia cells: relation to morphology and tumor immunity.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1974;145(3):790-3.
1974: Evan M Hersh; J U Gutterman; G M Mavligit
Perspectives in immunotherapy of lung cancer.
Cancer treatment reviews 1974;1(1):65-80.
1974: Evan M Hersh; K B McCredie; E J Freireich
Mechanism of production of inhibitor of lymphocyte blastogenic response to mitogens by cultured lymphoblastoid cell line cells.
Transplantation 1974;17(2):221-7.
1974: Evan M Hersh; B Drewinko
Specific inhibition of lymphocyte blastogenic responses to mitogens by a factor produced by cultured human malignant lymphoma cells.
Cancer research 1974;34(1):215-20.
1974: E J Freireich; E A Gehan; Gerald P Bodey; Evan M Hersh; J S Hart; J U Gutterman; K B McCredie
New progressive factors affecting response and survival in adult acute leukemia.
Transactions of the Association of American Physicians 1974;87():298-305.
1974: G Mavligit; J U Gutterman; C McBride; Evan M Hersh
Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current status.
Progress in experimental tumor research 1974;19():222-52.
1974: A V Jubert; C M Mc Bride; G Mavligit; J U Gutterman; Evan M Hersh
Immunoglobulins on the surface of human appendix lymphocytes.
Immunological communications 1974;3(1):1-9.
1974: Evan M Hersh; J U Gutterman; G Mavligit; C R Gschwind; M G Hanna
Human immune response to Rauscher leukemia virus.
Hämatologie und Bluttransfusion 1974;14():119-28.
1974: A H Johnson; Roger Rossen; Evan M Hersh; S S Farrow; W T Butler; W N Suki
Blastogenic suppression and alloantibody activity of sera from renal allograft recipients.
The Journal of clinical investigation 1974;53(1):270-8.
1973: J U Gutterman; G Mavligit; C McBride; E Frei; Evan M Hersh
Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
National Cancer Institute monograph 1973;39():205-12.
1973: A V Jubert; E T Lee; Evan M Hersh; C M McBride
Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence.
The Journal of surgical research 1973;15(6):399-403.
1973: B Drewinko; G Mavligit; U Ambus; C Pritchett; J Gutterman; Evan M Hersh
Brief communication: Specific colony inhibition by human lymphoma cells on an established human lymphoma cell line.
Journal of the National Cancer Institute 1973;51(4):1377-8.
1973: Evan M Hersh; J U Gutterman; G Mavligit; K B McCredie; Gerald P Bodey; E J Freireich; Roger Rossen; W T Butler
Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatment.
Transplantation proceedings 1973;5(3):1191-5.
1973: Evan M Hersh; Gerald P Bodey
First international symposium on clinical immunosuppression.
Transplantation proceedings 1973;5(3):1155-6.
1973: Evan M Hersh; C M McBride; C Gschwind
Local and systemic immunologic effects of perfusion therapy for malignant melanoma.
Surgery, gynecology & obstetrics 1973;137(3):461-4.
1973: G M Mavligit; J U Gutterman; Evan M Hersh
Primary brain tumors: tumor immunity and immunocompetence.
Surgical neurology 1973;1(5):261-3.
1973: G M Mavligit; J U Gutterman; Evan M Hersh; Roger Rossen; W T Butler; K B McCredie; E J Freireich
Lymphoma-associated and HL-A antigens in the mixed leukocyte reactivity between identical siblings.
Transplantation 1973;16(3):217-20.
1973: Evan M Hersh
Immunosuppressive enzymes.
Transplantation proceedings 1973;5(3):1211-4.
1973: G M Mavligit; Evan M Hersh; C M McBride
Lymphocyte blastogenic responses to autochthonous viable and nonviable human tumor cells.
Journal of the National Cancer Institute 1973;51(2):337-43.
1973: J Gutterman; G Mavligit; C McBride; E Frei; Evan M Hersh
BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.
Cancer 1973;32(2):321-7.
1973: J E Curtis; Evan M Hersh
Cellular immunity in man: correlation of leukocyte migration inhibition factor formation and delayed hypersensitivity.
Cellular immunology 1973;8(1):55-61.
1973: G M Mavligit; U Ambus; J U Gutterman; Evan M Hersh; C M McBride
Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
Nature: New biology 1973;243(127):188-90.
1973: J U Gutterman; G Mavligit; C McBride; E Frei; E J Freireich; Evan M Hersh
Active immunotherapy with B.C.G. for recurrent malignant melanoma.
Lancet 1973;1(7814):1208-12.
1973: G M Mavligit; J U Gutterman; C M McBride; Evan M Hersh
Cell-mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens.
National Cancer Institute monograph 1973;37():167-76.
1973: J U Gutterman; Evan M Hersh; G M Mavligit; E J Freireich; Roger Rossen; W T Butler; K B McCredie; Gerald P Bodey; V Rodriguez
Cell-mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen--relationship to immunocompetence and prognosis.
National Cancer Institute monograph 1973;37():153-65.
1973: Evan M Hersh
Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
National Cancer Institute monograph 1973;36():123-4.
1973: J U Gutterman; G Mavligit; K B McCredie; E J Freireich; Evan M Hersh
Auto-immunization with acute leukemia cells: demonstration of increased lymphocyte responsiveness.
International journal of cancer. Journal international du cancer 1973;11(3):521-6.
1973: A V Jubert; Evan M Hersh; C M McBride
Responses of appendix and peripheral blood lymphocytes to stimulation with various mitogens.
Surgery, gynecology & obstetrics 1973;136(4):567-73.
1973: H L Gordon; Roger Rossen; Evan M Hersh; J J Yium
Immunologic aspects of interstitial cystitis.
The Journal of urology 1973;109(2):228-33.
1973: J U Gutterman; Roger Rossen; W T Butler; K B McCredie; Gerald P Bodey; E J Freireich; Evan M Hersh
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia.
The New England journal of medicine 1973;288(4):169-75.
1973: J E Curtis; J T Sharp; M D Lidsky; Evan M Hersh
Immune response of patients with rheumatoid arthritis during cyclophosphamide treatment.
Arthritis and rheumatism 1973;16(1):34-42.
1973: G M Mavligit; J U Gutterman; Evan M Hersh
Separation of viable from non-viable tumor cells using Ficoll-Hypaque density solution.
Immunological communications 1973;2(5):463-72.
1973: S S Farrow; Roger Rossen; W N Suki; Evan M Hersh
Use of antiglobulin microcytotoxicity test and mixed leukocyte culture to evaluate prognosis in renal transplant recipients.
Proceedings of the Clinical Dialysis and Transplant Forum 1973;3():74-6.
1972: J U Gutterman; Evan M Hersh; K B McCredie; Gerald P Bodey; V Rodriguez; E J Freireich
Lymphocyte blastogenesis to human leukemia cells and their relationship to serum factors, immunocompetence, and prognosis.
Cancer research 1972;32(11):2524-9.
1972: L E Davis; Evan M Hersh; J E Curtis; R E Lynch; D K Ziegler; J W Neumann; T D Chin
Immune status of patients with multiple sclerosis. Analysis of primary and established immune responses in 24 patients.
Neurology 1972;22(10):989-97.
1972: J U Gutterman; G Mavligit; K B McCredie; Gerald P Bodey; E J Freireich; Evan M Hersh
Antigen solubilized from human leukemia: lymphocyte stimulation.
Science (New York, N.Y.) 1972;177(4054):1114-5.
1972: G Mavligit; J U Gutterman; C M McBride; Evan M Hersh
Multifaceted evaluation of human tumor immunity using a salt extracted colon carcinoma antigen.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1972;140(4):1240-5.
1972: R J Anderson; C M McBride; Evan M Hersh
In vitro lymphocyte responses to malignant, benign neoplastic and normal tissue extracts.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1972;140(2):465-70.
1972: R J Anderson; C M McBride; Evan M Hersh
Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.
Cancer research 1972;32(5):988-92.
1972: A R Cheema; Evan M Hersh
Local tumor immunotherapy with in vitro activated autochithonous lymphocytes.
Cancer 1972;29(4):982-6.
1972: G A LePage; Evan M Hersh
Cyclic nucleotide analogs as carcinostatic agents.
Biochemical and biophysical research communications 1972;46(5):1918-22.
1972: J E Curtis; Evan M Hersh; E J Freireich
Leukapheresis therapy of chronic lymphocytic leukemia.
Blood 1972;39(2):163-75.
1972: J E Curtis; Evan M Hersh
The human secondary immune response to Keyhole limpet haemocyanin.
Clinical and experimental immunology 1972;10(1):171-7.
1971: Evan M Hersh; J P Whitecar; K B McCredie; Gerald P Bodey; E J Freireich
Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia.
The New England journal of medicine 1971;285(22):1211-6.
1971: Evan M Hersh
Immunosuppression by L-asparaginase and related enzymes.
Transplantation 1971;12(5):368-76.
1971: A R Cheema; Evan M Hersh
Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis.
Cancer 1971;28(4):851-5.
1971: Evan M Hersh
Blastogenic responses of human lymphocytes to xenogeneic cells in vitro.
Transplantation 1971;12(4):287-93.
1971: Evan M Hersh; G A LePage
Effect of arabinosyl-6-mercaptopurine on the blastogenic responses in vitro of human lymphocytes to mitogenic agents.
Biochemical pharmacology 1971;20(9):2459-68.
1971: Evan M Hersh; W T Butler; Roger Rossen; R O Morgan; W Suki
In vitro studies of the human response to organ allografts: appearance and detection of circulating activation lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1971;107(2):571-8.
1971: J E Curtis; Evan M Hersh; W T Butler; Roger Rossen
Antigen dose in the human immune response. Dose-relationships in the human immune response to Keyhole limpet hemocyanin.
The Journal of laboratory and clinical medicine 1971;78(1):61-9.
1971: Evan M Hersh; B W Brown
Inhibition of immune responses by glutamine antagonism: effect of azotomycin on lymphocyte blastogenesis.
Cancer research 1971;31(6):834-40.
1971: Evan M Hersh
L-glutaminase: suppression of lymphocyte blastogenic responses in vitro.
Science (New York, N.Y.) 1971;172(3984):736-8.
1971: J Harris; R Alexanian; Evan M Hersh; P Migliore
Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyanin.
Canadian Medical Association journal 1971;104(5):389-93.
1971: Evan M Hersh; W T Butler; Roger Rossen; R O Morgen; W Suki
Lymphocyte activation during allograft rejection.
Transplantation proceedings 1971;3(1):457-60.
1971: K B McCredie; Evan M Hersh; E J Freireich
Cells capable of colony formation in the peripheral blood of man.
Science (New York, N.Y.) 1971;171(3968):293-4.
1970: J E Curtis; Evan M Hersh; E J Freireich
Antigen-specific immunity in recipients of leukocyte transfusions from immune donors.
Cancer research 1970;30(12):2921-9.
1970: R Ohno; J E Harris; Evan M Hersh
L-asparaginase: suppression of the immune response of mice to sheep red blood cells.
Clinical and experimental immunology 1970;7(2):221-7.
1970: R Ohno; Evan M Hersh
Immunosuppressive effects of L-asparaginase.
Cancer research 1970;30(6):1605-11.
1970: Evan M Hersh; W T Butler; Roger Rossen; R O Morgen
Lymphocyte activation: a rapid test to predict allograft rejection.
Nature 1970;226(5247):757-8.
1970: J E Harris; Evan M Hersh; S Huggins
Human immune response to a xenogeneic nucleated cell.
Transplantation 1970;9(5):440-6.
1970: Evan M Hersh; J E Harris; E A Rogers
Influence of cell density on response of leukocytes and column-purified lymphocytes to mitogenic agents.
Journal of the Reticuloendothelial Society 1970;7(5):567-86.
1970: J E Curtis; Evan M Hersh; J E Harris; C McBride; E J Freireich
The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.
Clinical and experimental immunology 1970;6(4):473-91.
1970: J E Harris; Evan M Hersh
The effect of the antitumor agent 1,1-diphenyl-2-propynyl cyclohexylcarbamate on the immune response of mice to sheep red blood cells.
Cancer research 1970;30(3):837-41.
1970: W T Butler; Roger Rossen; Evan M Hersh; A C Beall; R D Morgen; E B Diethrich; M E Debakey
Immunologic considerations for future cardiac transplantation in man.
Laval médical 1970;41(2):155-60.
1970: R Ohno; Evan M Hersh
The inhibition of lymphocyte blastogenesis by L-asparaginase.
Blood 1970;35(2):250-62.
1970: Evan M Hersh; Gerald P Bodey
Leukocytic mechanisms in inflammation.
Annual review of medicine 1970;21():105-32.
1969: Evan M Hersh; W S Irvin
Blastogenic responses of lymphocytes from patients with untreated and treated lymphomas.
Lymphology 1969;2(4):150-60.
1969: W T Butler; Roger Rossen; Evan M Hersh; M E DeBakey; E B Diethrich; D K Brooks; D A Cooley; J J Nora; R D Leachman; D G Rochelle; J J Trentin; K P Judd; A C Beall; D E Jenkins; R O Morgen; V Knight
Prevention of rapid immune elimination of anti-lymphocytic globulin in transplant patients.
Nature 1969;224(5222):856-60.
1969: J Harris; R Alexanian; Evan M Hersh; W Leary
Hodgkin's disease complicated by infection with Mycobacterium kansasii.
Canadian Medical Association journal 1969;101(4):231-4.
1968: J E Harris; Evan M Hersh
The effect of 1-beta-D-arabinofuranosylcytosine on the immune response of mice to sheep red blood cells.
Cancer research 1968;28(12):2432-6.
1968: J J Oppenheim; B G Leventhal; Evan M Hersh
The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli.
Journal of immunology (Baltimore, Md. : 1950) 1968;101(2):262-7.
1968: Evan M Hersh; J E Harris
Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes.
Journal of immunology (Baltimore, Md. : 1950) 1968;100(6):1184-94.
1968: Gerald P Bodey; Evan M Hersh; E J Freireich
Recurrent Listeria monocytogenes meningitis in a patient with acute leukemia.
Cancer 1968;21(4):619-22.
1967: Evan M Hersh; J J Oppenheim
Inhibition of in vitro lymphocyte transformation during chemotherapy in man.
Cancer research 1967;27(1):98-105.
1966: V G Wong; Evan M Hersh; P R McMaster
Treatment of a presumed case of sympathetic ophthalmia with methotrexate.
Archives of ophthalmology 1966;76(1):66-76.
1966: Gerald P Bodey; R D Powell; Evan M Hersh; A Yeterian; E J Freireich
Pulmonary complications of acute leukemia.
Cancer 1966;19(6):781-93.
1966: Evan M Hersh; V G Wong; E S Henderson; E J Freireich
Hepatotoxic effects of methotrexate.
Cancer 1966;19(4):600-6.
1966: Evan M Hersh; V G Wong; E J Freireich
Inhibition of the local inflammatory response in man by antimetabolites.
Blood 1966;27(1):38-48.
1965: Evan M Hersh; J J Oppenheim
Impaired in vitro lymphocyte transformation in Hodgkin's disease.
The New England journal of medicine 1965;273(19):1006-12.
1965: Evan M Hersh; P P Carbone; V G Wong; E J Freireich
Inhibition of the primary immune response in man by anti-metabolites.
Cancer research 1965;25(7):997-1001.
1965: Evan M Hersh; Gerald P Bodey; B A NIES; E J FREIREICH
CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963.
JAMA : the journal of the American Medical Association 1965;193():105-9.